Clinical trials: Specific Polysaccharide Antibody Deficiency
Specific Antibody Deficiency, Predominantly Antibody Deficiencies
Frequency of SPAD in Adult Patients
The DETECT study aims to demonstrate the importance of detecting SPAD in adult patients with recurrent benign and/or severe unexplained bacterial upper/lower respiratory tract infections.
- Trial name
- DETECT (NCT05664035)
- Testing
- Diagnosis of SPAD using immunization with PPV23
- Where
- France
- Volunteers
- 99 people
- Sponsor
- University Hospital, Lille
Specific Polysaccharide Antibody Deficiency
Polysaccharide Antibody Response Study
Specific polysaccharide antibody deficiency (SPAD) is a primary immunodeficiency characterized by a deficient antibody production to capsular polysaccharides with normal total immunoglobulin levels.
- Trial name
- PARS (NCT02429531)
- Testing
- Pneumovax 23 (Sanofi Pasteur MSD), Typhim Vi (Sanofi Pasteur MSD)
- Where
- Belgium
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Universitaire Ziekenhuizen KU Leuven